A detailed history of Crawford Investment Counsel Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 8,048 shares of LLY stock, worth $6.04 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,048
Previous 8,176 1.57%
Holding current value
$6.04 Million
Previous $7.4 Million 3.67%
% of portfolio
0.13%
Previous 0.14%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $98,833 - $122,882
-128 Reduced 1.57%
8,048 $7.13 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $273,275 - $342,708
377 Added 4.83%
8,176 $7.4 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $319,788 - $427,831
-540 Reduced 6.48%
7,799 $6.07 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1,050 - $1,238
-2 Reduced 0.02%
8,339 $4.86 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $100,415 - $138,438
-231 Reduced 2.69%
8,341 $4.48 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $323,733 - $432,868
923 Added 12.07%
8,572 $4.02 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $62,747 - $73,693
202 Added 2.71%
7,649 $2.63 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $37,299 - $43,461
-116 Reduced 1.53%
7,447 $2.72 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $154,762 - $176,368
-522 Reduced 6.46%
7,563 $2.45 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $60,484 - $71,017
-217 Reduced 2.61%
8,085 $2.62 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $165,221 - $205,328
-704 Reduced 7.82%
8,302 $2.38 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $39,123 - $48,552
-174 Reduced 1.9%
9,006 $2.49 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $68,696 - $84,540
-310 Reduced 3.27%
9,180 $2.12 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $16,430 - $21,252
-91 Reduced 0.95%
9,490 $2.18 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $15,446 - $19,995
-94 Reduced 0.97%
9,581 $1.79 Million
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $62,620 - $82,862
480 Added 5.22%
9,675 $1.63 Million
Q3 2020

Oct 29, 2020

SELL
$146.22 - $169.13 $6,872 - $7,949
-47 Reduced 0.51%
9,195 $1.36 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $38,061 - $45,806
-279 Reduced 2.93%
9,242 $1.52 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $398,698 - $493,475
-3,349 Reduced 26.02%
9,521 $1.32 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $111,517 - $138,124
1,043 Added 8.82%
12,870 $1.69 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $49,657 - $54,014
465 Added 4.09%
11,827 $1.32 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $68,689 - $80,178
-620 Reduced 5.17%
11,362 $1.26 Million
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $12,244 - $14,412
110 Added 0.93%
11,982 $1.56 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $847 - $949
8 Added 0.07%
11,872 $1.37 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $30,500 - $36,003
-411 Reduced 3.35%
11,864 $918,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $47,934 - $51,415
-585 Reduced 4.55%
12,275 $1.04 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $991,120 - $1.1 Million
12,860
12,860 $1.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Crawford Investment Counsel Inc Portfolio

Follow Crawford Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.